dihexa hgf c-met cancer risk mechanism of action HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence Dihexa: Mechanism, Effects & Research – Targeting cancer-associated fibroblast-activated HGF/c-MET pathway
Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Hepatocyte Growth Factor c Met Signaling in Head and Neck Cancer and Implications for Treatment c MET: A Key Target in Cancer Therapy HGF and MET: From Brain Development to Neurological Disorders PMC The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion Cell Communication and Signaling Springer Nature Link
Pay in 4 interest-free payments of $6.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11





